Previous Article | Next Article ![]()
Applied and Environmental Microbiology, October 2004, p. 5756-5763, Vol. 70, No. 10
0099-2240/04/$08.00+0 DOI: 10.1128/AEM.70.10.5756-5763.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
Department of Applied Chemistry and Microbiology,1 Department of Biological and Environmental Sciences University of Helsinki, Helsinki, Finland2
Received 12 March 2004/ Accepted 1 June 2004
| ABSTRACT |
|---|
|
|
|---|
| INTRODUCTION |
|---|
|
|
|---|
Most microcystins are potent inhibitors of eukaryotic protein phosphatases 1 and 2A (26). Microcystins have been commonly involved in domestic and wild animal poisonings (36) and pose a threat to human health (23). Microcystins are toxic to zooplankton, and it is widely believed that they act as a grazing deterrent to zooplankton, which graze on cyanobacteria (9, 21). They are also proposed to act in cyanobacterial cell-to-cell communication (11) and as a chelator in iron scavenging (46).
Microcystins are comprised of seven amino acids that form a ring structure. The general structure of microcystins is cyclo[-D-Ala-L-X-D-MeAsp-L-Z-Adda-D-Glu-Mdha-], of which Z and X are variable L-amino acids (Fig. 1). There are more than 65 structural variants of microcystins known (39). The most commonly reported microcystin variant (microcystin-LR) contains L-leucine (L) and L-arginine (R) in the variable X and Z positions (Fig. 1). The novel amino acid Adda (3-amino-9-methoxy-2,6,8,-trimethyl-10-phenyl-deca-4,6-dienoic acid) is found only in microcystins and nodularins (39, 47) and plays a crucial role in the inhibition of eukaryotic protein phosphatases (16). There are three structural modifications to the Adda amino acid known, geometrical isomers (6Z-Adda) (17), an acetyl-demethyl variant (ADMAdda) (47), and a demethyl variant (DMAdda) (47). The geometrical isomer of Adda is biologically inactive (17), whereas the two other modifications inhibit protein phosphatases (3, 40, 42).
|
Nostoc is a cosmopolitan cyanobacterial genus occurring in both terrestrial and aquatic ecosystems. Strains of the genus Nostoc are the most common cyanobacteria in various symbioses (13). Nostoc strains can also occur as a minor component of cyanobacterial blooms but rarely form mass occurrences (40). Nostoc collected from terrestrial habitats is used as a dietary supplement by humans in some countries, but no acute intoxications attributed to microcystins have been reported (13, 15). A Nostoc rivulare bloom in Texas caused intoxication of wild and domestic animals (8, 39). However, despite the screening of cyanobacterial cultures and strains for microcystins and other bioactive compounds during the last decade (34, 39), only two strains of the genus Nostoc, Nostoc sp. strain 152 isolated from Lake Sääskjärvi in Finland (40, 42) and Nostoc sp. strain DUN901 isolated from brackish water of Barrow Ski Club Lake in the United Kingdom (3), are known to synthesize microcystins. Of the more than 65 known microcystin variants, 10 are produced by Nostoc sp. strains 152 and DUN901, and all are acutely hepatotoxic (3, 40).
We screened Nostoc strains involved in lichen symbiosis for microcystin production. A single Nostoc strain was found to produce microcystins. We analyzed the structures of the microcystins with liquid chromatography (LC) combined with mass spectrometry (MS). We also evaluated the phylogenetic position of the microcystin-producing Nostoc strain by constructing and comparing phylogenetic trees from microcystin synthetase genes mcyA, mcyD, and mcyE and from the 16S rRNA and rpoC1 genes.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Whole-cell extraction.
Freeze-dried cells from a 42-day-old Nostoc sp. strain IO-102-I (39 or 66 mg) and from a 21-day-old Nostoc sp. strain 152 (42 mg) culture were homogenized with a glass-bead method as follows. Cells were mixed with glass beads of sizes 425 to 600 µm and 710 to 1,180 µm and 1 ml of 85% acetonitrile (ACN). The mixture was shaken in a FastPrep (FP120; Bio 101 Savant) cell disrupter twice at speed 5.0 for 40 s and then centrifuged at 10,000 x g for 3 min. The supernatant was passed sequentially through two solid-phase extraction cartridges (StrataX Polymeric Sorbent, 30 mg; particle size, 33 µm; pore size, 85 Å; Phenomenex, Torrance, Calif.) equilibrated with 1 ml of 85% ACN and evaporated in a 100-Pa vacuum. The residue was dissolved into 200 µl of 15% ACN and passed through a 0.2-µm-pore-size filter (GHP Acrodisc; Pall Galman Laboratory, Ann Harbor, Mass.).
ELISA.
Microcystins from the 1,000-fold dilution of the whole-cell extract were screened with the competitive enzyme-linked immunosorbent assay (ELISA) by using a microcystins plate kit (Strategic Diagnostics, Inc., Newark, Del.) and detected with a microplate optical reader (iEMS Reader MF; Labsystems, Helsinki, Finland).
Protein phosphatase inhibition assay.
To test the inhibition of the alpha-isoform of type 1 protein phosphatase from rabbit skeletal muscle by the Nostoc sp. strain IO-102-I, a colorimetric inhibition assay (2) was used with minor modifications as follows. First, 10 µl of the whole-cell extract was diluted with distilled H2O to 10-, 100-, or 1,000-fold and added to the phosphatase inhibition assay. A total of 5 U of the PP1 enzyme/ml expressed in Escherichia coli (New England Biolabs, Inc., Beverly, Mass.) was dissolved in enzyme buffer. The substrate concentration was 15 mM, and incubation of the reaction before optical detection (iEMS Reader MF; Labsystems, Helsinki, Finland) was extended to 40 min.
Microcystin structures.
Whole-cell extracts were analyzed by high-pressure LC (HPLC) by injecting 10 µl of extract into the HP 1100 series modular HPLC system (Agilent Technologies, Palo Alto, Calif.) equipped with a diode array detector. A Zorbax SB-C18 column (2.1 by 50 mm; particle diameter of the stationary phase, 3.5 µm; Agilent Technologies) and a mobile phase gradient of 18% (0 min) to 20.5% (35 min) ACN-10 mM ammonium formate at a flow rate of 0.3 ml min1 at 40°C were used. Microcystins were distinguished from other peptides based on their characteristic UV maximum absorbance of 238 nm. An ion-trap Esquire mass spectrometer (Bruker Daltonics, Bremen, Germany) directly connected to the liquid chromatograph was used to identify microcystins. Electrospray ionization was performed in positive ion mode. The capillary voltage was set to 3,270 V, the capillary exit offset was 1,300 V, the skimmer 1 potential was 58 V, and the trap drive value was 62. The nebulizer gas (N2) pressure was 40 lb/in2 (40 lb/in2 = 275,792 Pa), the drying gas (N2) flow rate was 9 liters min1, and the drying temperature was 365°C. Spectra were recorded at a scan range of 100 to 1,500 m/z and a scanning rate of 13,000 m/z s1. The fragmentation amplitude range was 0.6 to 1.0 in tandem MS (MS/MS) mode.
DNA amplification and sequencing.
DNA was extracted from Nostoc sp. strain IO-102-I by using the DNEasy plant kit (Qiagen, Hilden, Germany). To resolve the relationship between the microcystin synthetase genes from Nostoc sp. strain IO-102-I and other microcystin synthetase gene clusters, we amplified and sequenced the 16S rRNA gene (35) and portions of the mcyA (18), mcyD, mcyE, and rpoC1 genes as previously described (35). It was not possible to sequence the mcyA PCR product from Nostoc sp. strain IO-102-I directly due to the coamplification of nonspecific fragments. Instead, a band of the expected length was cut out from a gel, purified, and cloned by using the TOPO cloning kit (Invitrogen, Groningen, The Netherlands). Three cloned mcyA gene fragments were sequenced with two primers anchored in the pCR2.1-TOPO vector: M13F (20) and M13R. The amplified 16S rRNA region was sequenced by using sets of internal primers (14). PCR products were cycle sequenced by using a BigDye terminator cycle sequencing kit (Applied Biosystems, Foster City, Calif.) and analyzed on an ABI Prism 310 genetic analyzer (Applied Biosystems).
Phylogenetic DNA sequence analyses.
The 16S rRNA sequences, except for that from the Nostoc sp. strain IO-102-I, which was sequenced for the present study, were obtained from GenBank at the National Center for Biotechnology Information (NCBI). The 16S rRNA gene sequence alignment used to construct the tree in Fig. 2 contained 1,388 characters. The 16S rRNA and the mcyA, mcyD, mcyE, and rpoC1 gene regions for trees in Fig. 3 contained 1447, 250, 780, 769, and 682 characters, respectively. The best-fitting nucleotide substitution model was determined by testing 56 different models (33) for the 1,388-character 16S rRNA sequence alignment in PAUP 4.0b10. The model was chosen with the Modeltest 3.06 program by using the Akaike information criterion (32). The general time-reversible model was used for every data set as the best-fitting nucleotide substitution model in Bayesian phylogenetic inference applied with MrBayes 3.0b4 (19, 20). MrBayes implements a Markov Chain Monte Carlo method that runs many chains simultaneously. Four chains were performed for a million generations; every hundredth was sampled, generating a total of 10,000 trees, with each run in two separate runs with a random starting tree. Unstable initial burn-in cycles were removed (10%). A majority rule consensus tree from the stationary phase was viewed with TreeView 1.6.6 (30).
|
|
Sequence accession numbers.
New DNA sequences from Nostoc sp. strain IO-102-I were deposited in GenBank under accession numbers AY566855 (16S rRNA), AY566856 (mcyA), AY566857 (mcyD), AY566858 (mcyE), and AY566859 (rpoC1).
| RESULTS |
|---|
|
|
|---|
Microcystin variants.
The total concentration of microcystin variants in the Nostoc sp. strain IO-102-I was 0.2 µg mg1 (dry weight). Six microcystin peaks were detected by LC-UV/MS/MS according to their characteristic UV absorbance originating from the conjugated double bond in the Adda structure, the microcystin characteristic protonated molecular ions (M+H+), and fragment ions from the M+H+. In the LC-UV/MS analysis there were one major and five minor peaks of microcystins with molecular masses of 1,022, 980, 1,008, 1,022, 1,036, and 1,076 Da, respectively (Tables 1 and 2) . The major microcystin peak accounted for
80% of the total microcystins, and the minor microcystin peaks comprised 1 to 10% each of the total microcystins (2).
|
|
Another microcystin (<10%) with a molecular mass of 1,022 was also present and shared identical characteristic ions with [ADMAdda5]microcystin-LR but clearly had a smaller retention time (Table 2). The smaller retention time of this microcystin variant was due to its weaker hydrophobicity compared to the major variant 1022. The full structure of this previously unreported [ADMAdda5]microcystin variant remained unresolved.
A third microcystin (
2%) had a mass (980 Da) identical to those of the [D-Asp3], [DMAdda5], and [Dha7] variants of microcystin-LR (39). The microcystin diagnostic ion m/z 553, [Mdha-Ala-Leu-MeAsp-Arg + H+], and the DMAdda structure specific ion m/z 585, [Arg-DMAdda-Glu + H+], were the most abundant peaks in the spectrum (Table 1). The Adda specific ion m/z 135 was missing from the spectrum. Thus, LC-MS/MS fragmentation analysis suggested that this variant was [DMAdda5]microcystin-LR.
A fourth microcystin (
2%) had a mass (1,008 Da) identical to that of microcystin-HilR, [D-Asp3, ADMAdda5], and [D-Glu(OCH3)6] variants of microcystin-LR (39). The MS/MS spectra of the m/z 1009 ion had a fragment ion pattern similar to that reported previously (47) from the [D-Asp3, ADMAdda5] microcystin-LR, including the important diagnostic ions m/z 539 [Mdha-Ala-Leu-Asp-Arg + H+] and m/z 627 [Arg-ADMAdda-Glu + H+] (Table 1).
The remaining two minor (
2% and <10%) microcystin variants from Nostoc sp. strain IO-102-I with molecular masses of 1,036 and 1,076 Da fragmented to the prominent ADMAdda diagnostic ion m/z 627 [Arg-ADMAdda-Glu + H+] (47) (Table 1). The diagnostic ion for [Mdha-Ala-Leu-MeAsp-Arg + H+] with an m/z of 553 was not found in these three variants (Table 1). The previously reported variant [ADMAdda5]microcystin-LHar from Nostoc sp. strain 152 had a molecular mass of 1,036 Da (39). However, these two variants had different retention times (Table 2) and different mass fragmentation patterns (47), and therefore these two microcystins do not have an identical structure (Table 2). The diagnostic ion m/z 627 (Table 1) excluded the possibility of the L-Har amino acid that gave the ion m/z 641 in this fragment (47). In this new microcystin 1036, the ions for [MeAsp-Arg-ADMAdda-Glu + H+], [MeAsp-Arg - NH2 + 2H+] and [Arg-ADMAdda-Glu-Mdha-Ala + H+] had the same m/z with the ions from [ADMAdda5]microcystin-LR, but ions from leucine-containing fragments were 14 mass units bigger (Table 1), meaning that most probably microcystin 1036 varied from [ADMAdda5]microcystin-LR in position 2 (Fig. 1). Similarly, in microcystin 1076 the ions for [MeAsp-Arg-ADMAdda-Glu + H+], [MeAsp-Arg + 2H+], and [Arg-ADMAdda-Glu-Mdha-Ala + H+] had the same m/z with the ions from [ADMAdda5]microcystin-LR, but ions from fragments containing position 2 amino acids were 54 mass units bigger (Table 1). Thus, the two partly resolved structures are ADMAdda-XR-type microcystins that contain unidentified amino acid(s), most probably in position 2 (Fig. 1). The molecular mass of 1,076 Da is new (39). The reference Nostoc sp. strain 152 produced more microcystin variants than previously reported (42).
BLAST search.
Nostoc punctiforme PCC 73102, a close relative to Nostoc sp. strain IO-102-I, contains nonribosomal peptide synthetase gene clusters (27). However, BLAST searches indicated that the microcystin synthetase genes were not present in genomes of N. punctiforme PCC 73102. The two more distant relatives, Nostoc sp./Anabaena sp. strain PCC 7120 and A. variabilis ATCC 29413, did not contain the microcystin synthetase genes either.
Phylogenetic analyses.
The 16S rRNA gene tree demonstrated that the two microcystin-producing Nostoc sp. strains 152 and IO-102-I were distantly related (Fig. 2). Among available Nostoc 16S rRNA sequences, the closest relative to Nostoc sp. strain IO-102-I was Nostoc sp. strain ATCC 53789, also isolated from lichen in Scotland (Fig. 2). Nostoc sp. strain IO-102-I formed a monophyletic group with the reference strain of N. punctiforme strain PCC 73102 and several other strains originating from symbioses. N. punctiforme strain PCC 73102 and Nostoc sp. strain IO-102-I had a 98% sequence similarity in the 1,405-nt 16S rRNA region. All of these Nostoc strains shared a recent common ancestor with other terrestrial Nostoc strains from symbiotic associations unlike microcystin-producing, planktonic Nostoc sp. strain 152, which fell outside the main Nostoc clade as a distant relative (Fig. 2). Nostoc sp. strain IO-102-I grouped with Nostoc sp. strain 152 in the tree inferred from the three microcystin synthetase genes (Fig. 3A), indicating that the closest known relative producing microcystin also shared the closest gene cluster with the terrestrial Nostoc sp. strain IO-102-I. The microcystin synthetase gene tree genes resulted in relationships that were well supported at all nodes except for the node uniting Nostoc sp. strains IO-102-I and 152 (Fig. 3A). This was consistent with strain relationships inferred from 16S rRNA gene sequences (Fig. 3B and Fig. 2). In the 1,428-nt 16S rRNA gene region there was a considerable 6% sequence difference between Nostoc sp. strains 152 and IO-102-I.
| DISCUSSION |
|---|
|
|
|---|
The previously described microcystin variants from Nostoc sp. strain 152 (42) that Nostoc sp. strain IO-102-I also produced were hepatotoxic. The toxicity (as indicated by the 50% lethal dose) in a mouse bioassay of the dominating variant [ADMAdda5]microcystin-LR was one of highest among microcystins (39), but the total concentration of microcystins in Nostoc sp. strain IO-102-I was 10-fold smaller than in Nostoc sp. strain 152.
The finding of microcystins from terrestrial Nostoc sp. strain IO-102-I broadens the range of ecological habitats in which microcystin production has been documented. All known producers, with the exception of Hapalosiphon hibernicus BZ-3-1 originating from soil or fresh-water mud (34), are aquatic and present in freshwater and brackish water bodies (39). Thus, to our knowledge Nostoc sp. strain IO-102-I is the third Nostoc and the second terrestrial strain capable of producing microcystin. One reason for the rarity of microcystin production in the terrestrial environment may be its scattered distribution, shown here within the terrestrial Nostoc lineage. Since the clade in the 16S rRNA tree that contained Nostoc sp. strain IO-102-I also contained strains that did not produce microcystins (25), the distribution of microcystin production is not spread evenly throughout the current terrestrial Nostoc lineage. In the terrestrial Nostoc strains microcystin production was not spread throughout the phylogenetic lineage. Scattered distribution of microcystin production has also been found with Microcystis (25, 45) and Planktothrix (25) spp., but in Nostoc strains the production is likely to be even more scattered. The scattered distribution of microcystin production in cyanobacteria shows that the ability to produce secondary metabolites does not necessarily depend on how closely related the strains are. Phylogenetic congruence between the microcystin synthetase genes (mcyADE) and the housekeeping genes (16S rRNA, rpoC1) suggests that both Nostoc sp. strains IO-102-I and 152 inherited the microcystin synthetase gene cluster from a common ancestor. Since it is not known why cyanobacteria produce microcystins, it is difficult to speculate how probable the loss of the gene cluster is and if loss of the cluster is linked to habitat. The sequence differences from both the housekeeping and microcystin synthetase genes indicate that the two Nostoc strains, 152 and IO-102-I, diverged a long time ago or rapidly at some point. Nostoc sp. strain IO-102-I is in a same evolutionary lineage with symbiotic Nostoc sp. strain ATCC 53789 and N. punctiforme strain PCC 73102 with a very high sequence similarity, suggesting that it most likely belongs to that species. Another reason why microcystin production in a terrestrial environment has not been detected may be that terrestrial cyanobacteria have not been tested for microcystin production as frequently as cyanobacteria from aquatic habitats.
It is interesting that microcystins, which inhibit eukaryotic protein phosphatases 1 and 2A, were found in lichen symbiosis. It is possible that microcystin does not control fungal or algal growth directly in lichen symbiosis and therefore microcystin could be produced by cyanobacteria in symbiosis. Microcystins in vertebrates are transported across the cell membrane by bile acid carrier proteins, which are found only in hepatocytes in liver (6). Therefore, fungi might be incapable of transporting microcystins into its cells. Microcystin-LR is known to inhibit the photosynthesis of green algae (38). However, it affected algal growth at concentrations not encountered in their natural environment and did not affect the growth of fungi even at high doses (38, 39).
It is now known that the terrestrial Nostoc sp. strain IO-102-I and Hapalosiphon hibernicus strain BZ-3-1 (34) produce several toxic microcystins. Therefore, we need to consider that also terrestrial populations of cyanobacteria may represent a potential health hazard. Although no acute intoxications attributed to microcystins have been reported from areas in which Nostoc is used as human dietary supplement (13, 15), there may be a risk because microcystins act as liver tumor promoters at sublethal concentrates (28). In China, increased liver cancer in the human population has been linked to drinking water containing toxigenic cyanobacteria (4). Therefore, since there might be hazardous substances in subacute concentrations, the content of metabolites in consumed cyanobacteria should be studied. Reindeer feed on cyanobacterial lichens, e.g., on species Stereocaulon paschale, that are poorly digestible (43) but avoid cyanobacterial lichens in heavily grazed areas (10). Could the preference for green-algal lichens be due to the presence of toxic cyanobacterial secondary metabolites?
It would be worth studying the capacity of Nostoc strains to produce secondary metabolites. Sixteen metabolites with bioactivities, such as anticancer, antibiotic, antifungal, and antiviral properties, have already been found in seven Nostoc strains (5). For example, a synthetic analog derived from cryptophycin, a cytotoxic depsipeptide, isolated originally from a terrestrial Nostoc GSV224 strain, was chosen for clinical evaluation because of its antimitotic and antitumor effects (31).
To conclude, highly toxic microcystins were found in a terrestrial Nostoc strain. The toxicity of cyanobacteria therefore cannot be predicted from their habitat or from the strain identity because even closely related terrestrial cyanobacteria may vary in the production of secondary metabolites.
| ACKNOWLEDGMENTS |
|---|
This study was financially supported by grants from the Academy of Finland to K.S. (projects 53305, 201576, and 02162) and by a young scientist's grant from the Emil Aaltonen Foundation to I.O.
| FOOTNOTES |
|---|
| REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | Microbiol. Mol. Biol. Rev. | Eukaryot. Cell | All ASM Journals |
|---|